Daniel N. Masica

1.4k total citations
23 papers, 1.1k citations indexed

About

Daniel N. Masica is a scholar working on Pharmacology, Clinical Psychology and Oncology. According to data from OpenAlex, Daniel N. Masica has authored 23 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pharmacology, 5 papers in Clinical Psychology and 5 papers in Oncology. Recurrent topics in Daniel N. Masica's work include Treatment of Major Depression (5 papers), Bone health and osteoporosis research (4 papers) and Bone health and treatments (3 papers). Daniel N. Masica is often cited by papers focused on Treatment of Major Depression (5 papers), Bone health and osteoporosis research (4 papers) and Bone health and treatments (3 papers). Daniel N. Masica collaborates with scholars based in United States, Argentina and Germany. Daniel N. Masica's co-authors include Charles M. Beasley, Janet H. Potvin, Mary E. Sayler, Alvin H. Rampey, Bruce E. Dornseif, J C Bosomworth, Denis Murphy, Alicia Gilsenan, Elizabeth Andrews and Beth Sherrill and has published in prestigious journals such as Journal of Bone and Mineral Research, Journal of Affective Disorders and Psychopharmacology.

In The Last Decade

Daniel N. Masica

23 papers receiving 980 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel N. Masica United States 14 336 255 249 234 223 23 1.1k
S. Gunawardene United States 8 66 0.2× 119 0.5× 561 2.3× 127 0.5× 166 0.7× 8 1.4k
Brinda Wiita United States 16 52 0.2× 133 0.5× 300 1.2× 109 0.5× 222 1.0× 27 1.5k
Deborah Quail United Kingdom 20 359 1.1× 48 0.2× 265 1.1× 69 0.3× 25 0.1× 44 1.2k
G. Crawford United Kingdom 13 68 0.2× 179 0.7× 82 0.3× 147 0.6× 117 0.5× 26 931
Morten Steen Hansen Denmark 17 78 0.2× 44 0.2× 509 2.0× 48 0.2× 107 0.5× 28 966
Luisa Aliste Spain 13 103 0.3× 35 0.1× 411 1.7× 103 0.4× 93 0.4× 25 677
Diane Mickley United States 14 33 0.1× 191 0.7× 282 1.1× 49 0.2× 99 0.4× 22 1.3k
Eileen B. Brown United States 13 302 0.9× 73 0.3× 311 1.2× 14 0.1× 19 0.1× 17 866
Alfredo Ortega‐Alonso Finland 18 304 0.9× 61 0.2× 378 1.5× 14 0.1× 180 0.8× 44 1.0k
Jordi Carbonell Spain 12 496 1.5× 37 0.1× 671 2.7× 50 0.2× 29 0.1× 28 1.0k

Countries citing papers authored by Daniel N. Masica

Since Specialization
Citations

This map shows the geographic impact of Daniel N. Masica's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel N. Masica with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel N. Masica more than expected).

Fields of papers citing papers by Daniel N. Masica

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel N. Masica. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel N. Masica. The network helps show where Daniel N. Masica may publish in the future.

Co-authorship network of co-authors of Daniel N. Masica

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel N. Masica. A scholar is included among the top collaborators of Daniel N. Masica based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel N. Masica. Daniel N. Masica is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Silverman, Stuart L., Paul D. Miller, Anthony Sebba, et al.. (2013). The Direct Assessment of Nonvertebral Fractures in Community Experience (DANCE) study: 2-year nonvertebral fragility fracture results. Osteoporosis International. 24(8). 2309–2317. 42 indexed citations
2.
Andrews, Elizabeth, Alicia Gilsenan, Kirk Midkiff, et al.. (2012). The US postmarketing surveillance study of adult osteosarcoma and teriparatide: Study design and findings from the first 7 years. Journal of Bone and Mineral Research. 27(12). 2429–2437. 194 indexed citations
3.
Hadji, Peyman, José Zanchetta, Luis Augusto Tavares Russo, et al.. (2011). Effect of teriparatide compared with risedronate on back pain and incident vertebral fractures in postmenopausal women with osteoporotic vertebral fractures. Bone. 48. S82–S83. 2 indexed citations
4.
Hadji, Peyman, José Zanchetta, Luis Augusto Tavares Russo, et al.. (2011). The effect of teriparatide compared with risedronate on reduction of back pain in postmenopausal women with osteoporotic vertebral fractures. Osteoporosis International. 23(8). 2141–2150. 98 indexed citations
5.
Gilsenan, Alicia, et al.. (2009). The European postmarketing adult Osteosarcoma Surveillance Study: characteristics of patients A preliminary report. Acta Orthopaedica. 80(334). 67–74. 9 indexed citations
6.
Gold, Deborah T., et al.. (2006). Initial experience with teriparatide in the United States. Current Medical Research and Opinion. 22(4). 703–708. 20 indexed citations
7.
Hyslop, David L., Holly A. Read, Daniel N. Masica, & James G. Kotsanos. (2002). Pharmaceutical risk management: a call to arms for pharmacoepidemiology. Pharmacoepidemiology and Drug Safety. 11(5). 417–420. 3 indexed citations
8.
Gooch, W M, et al.. (1999). Loracarbef versus clarithromyin in children with acute otitis media with effusion. Clinical Therapeutics. 21(4). 711–722. 7 indexed citations
9.
Hamilton, S.H., et al.. (1997). Fluoxetine in Medically Stable, Depressed Geriatric Patients. Journal of Clinical Psychopharmacology. 17(5). 365–369. 23 indexed citations
10.
Goldstein, D., Alvin H. Rampey, Janet H. Potvin, Daniel N. Masica, & Charles M. Beasley. (1993). Analyses of suicidality in double-blind, placebo-controlled trials of pharmacotherapy for weight reduction.. PubMed. 54(8). 309–16. 12 indexed citations
11.
Masica, Daniel N., et al.. (1993). Possible Monoamine Oxidase Inhibitor-Serotonin Uptake Inhibitor Interaction. Journal of Clinical Psychopharmacology. 13(5). 312???320–312???320. 63 indexed citations
12.
Beasley, Charles M., Janet H. Potvin, Daniel N. Masica, et al.. (1992). Fluoxetine: no association with suicidality in obsessive-compulsive disorder. Journal of Affective Disorders. 24(1). 1–10. 30 indexed citations
13.
Beasley, Charles M., Daniel N. Masica, & Janet H. Potvin. (1992). Fluoxetine: a review of receptor and functional effects and their clinical implications. Psychopharmacology. 107(1). 1–10. 96 indexed citations
14.
Heiligenstein, John H., Emil F. Coccaro, Janet H. Potvin, et al.. (1992). Fluoxetine Not Associated With Increased Violence or Aggression in Controlled Clinical Trials. Annals of Clinical Psychiatry. 4(4). 285–295. 7 indexed citations
15.
Wheadon, David E., et al.. (1992). Lack of association between fluoxetine and suicidality in bulimia nervosa.. PubMed. 53(7). 235–41. 27 indexed citations
16.
Beasley, Charles M., Bruce E. Dornseif, J C Bosomworth, et al.. (1992). Fluoxetine and Suicide. International Clinical Psychopharmacology. 6. 35–57. 9 indexed citations
17.
Beasley, Charles M., et al.. (1990). Fluoxetine in tricyclic refractory major depressive disorder. Journal of Affective Disorders. 20(3). 193–200. 35 indexed citations
18.
Masica, Daniel N.. (1983). Report to Congress on Physician Exchange Visitor Programs.. 3 indexed citations
19.
Masica, Daniel N., John Money, & Anke Α. Ehrhardt. (1971). Fetal feminization and female gender identity in the testicular feminizing syndrome of androgen insensitivity. Archives of Sexual Behavior. 1(2). 131–142. 60 indexed citations
20.
Nager, George T. & Daniel N. Masica. (1970). Meningiomas of the cerebello‐pontine angle and their relation to the temporal bone: General considerations about posterior fossa meningiomas. The Laryngoscope. 80(6). 863–895. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026